March 18–19, 2021
Cancer treatment has evolved significantly over the past decade from a treatment paradigm anchored on surgery, chemotherapy, and radiotherapy, to one embracing molecularly-targeted therapies disrupting tumor-specific signaling pathways, as well as new approaches to mobilize the immune system. For physicians in clinical practice trying to keep pace with advancing immuno-oncology principles and research, the pace of these developments have brought new challenges. Recognizing these challenges, this course will provide a comprehensive clinical review of the advances taking place in the immuno-oncology field. It is suited to those practicing oncologists and professionals interested in learning more about immune-oncology approaches and the challenges of managing patients with new agents. The course is designed to enhance learners’ competence and performance in practice and will engage learners through interactive Q&A sessions with the faculty, along with didactic presentations.
Upon completion of this activity, participants will be able to:
- Evaluate cancer immunotherapy principles and strategies (cellular therapy, immune checkpoint inhibition, resistance to therapy, etc,) and how they influence current treatment approaches.
- Identify the emerging role of personalized cancer vaccination and other immunotherapy combinations in patients with solid tumor and hematologic malignancies.
- Recognize the importance of establishing a multidisciplinary approach in the immunotherapy era.
- Recognize and implement management strategies for immune-mediated side effects in patients treated with immunotherapy agents.
This course is targeted to Specialty Physicians, Nurse Practitioners, Physician Assistants. This course may also be of interest to physicians who practice in Allergy and Immunology, Oncology and Hematology, Radiation Oncology, Surgical Oncology and Immuno-Oncology.
Past Event Videos
View videos from the 2019 Advances in Cancer Immunotherapy CME Course.
- Section Head, Melanoma/Sarcoma Surgery
- Surgical Director, Termeer Center for Targeted Therapies
- Director, Therapeutic Intralesional Program
- Director, Center for Thoracic Cancers
- Director of Targeted Immunotherapy
- Assistant Professor of Medicine at Harvard Medical School
- Surgical Oncology
- Department of Surgery
- Director, Cellular Immunotherapy Program
- Associate Professor of Medicine, Harvard Medical School
- Instructor at Harvard Medical School
- Clinical Director, Inpatient Oncology Units
- Director, Severe Immunotherapy Complications Program
- Department of Medicine
- Assistant Clinical Attending